0001225208-24-006430.txt : 20240529
0001225208-24-006430.hdr.sgml : 20240529
20240529170426
ACCESSION NUMBER: 0001225208-24-006430
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240528
FILED AS OF DATE: 20240529
DATE AS OF CHANGE: 20240529
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Butcher Arthur C
CENTRAL INDEX KEY: 0001678249
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-11083
FILM NUMBER: 24999466
MAIL ADDRESS:
STREET 1: C/O BOSTON SCIENTIFIC CORPORATION
STREET 2: 300 BOSTON SCIENTIFIC WAY
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BOSTON SCIENTIFIC CORP
CENTRAL INDEX KEY: 0000885725
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 042695240
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 300 BOSTON SCIENTIFIC WAY
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752-1234
BUSINESS PHONE: 508-683-4000
MAIL ADDRESS:
STREET 1: 300 BOSTON SCIENTIFIC WAY
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752-1234
4
1
doc4.xml
X0508
4
2024-05-28
0000885725
BOSTON SCIENTIFIC CORP
BSX
0001678249
Butcher Arthur C
300 BOSTON SCIENTIFIC WAY
MARLBOROUGH
MA
01752-1234
1
EVP& Grp Pres, MedSurg & APAC
1
Common Stock
2024-05-28
4
M
0
3177.0000
22.7100
A
33199.0000
D
Common Stock
2024-05-28
4
M
0
1009.0000
17.2600
A
34208.0000
D
Common Stock
2024-05-28
4
S
0
14011.0000
75.3401
D
20197.0000
D
Common Stock
2539.0000
I
By 401(k)
Stock Option (Right to Buy)
17.2600
2024-05-28
4
M
0
1009.0000
0.0000
D
2026-02-22
Common Stock
1009.0000
6054.0000
D
Stock Option (Right to Buy)
22.7100
2024-05-28
4
M
0
3177.0000
0.0000
D
2026-06-01
Common Stock
3177.0000
19059.0000
D
The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 22, 2023.
Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $75.02 to $75.71, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Balance reflects the most current data available with regard to share holdings in the Company's 401(k) Retirement Savings Plan.
Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant.
Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on June 1, 2017, the first anniversary of the date of grant.
/s/ Susan Thompson, Attorney-in-Fact
2024-05-29